Semaglutide Cost: What to Actually Expect in 2026
GLP-1 pricing ranges wildly depending on brand vs. compounded, insurance vs. cash-pay, and provider markups. Here's the honest breakdown.
Quick answer: Semaglutide pricing varies based on whether patients choose brand-name options like Wegovy, which often exceeds one thousand dollars monthly without insurance, or compounded alternatives ranging from three hundred to five hundred dollars monthly. Insurance coverage typically depends on specific plan policies and indications such as diabetes rather than weight loss alone. Heyday plans start at two hundred ninety-nine dollars monthly on an annual commitment, which includes medication and provider oversight after clinical evaluation.
Start here: testosterone therapy at HeydayMD · could it be low testosterone? · at-home testing
The Price Landscape
Brand Name vs. Compounded
Wegovy (brand semaglutide): Manufactured by Novo Nordisk. Retail price exceeds $1,300/month without insurance. With insurance, copays typically range from $25-200/month depending on your plan — but many insurers don't cover it for weight loss, only for diabetes.
Compounded semaglutide: Made by licensed 503A/503B compounding pharmacies using the same active ingredient. Significantly less expensive ($300-500/month through most providers). This is how the majority of telehealth clinics — including Heyday — provide GLP-1 therapy at accessible prices.
What Heyday Charges
Heyday's GLP-1 plans start at $299/month (annual) and include medication, provider oversight, dosing titration, and ongoing monitoring. No hidden fees for consultations or dose adjustments. The medication ships monthly in discreet packaging.
Insurance & HSA/FSA
Most insurance plans cover semaglutide for type 2 diabetes (as Ozempic) but not for weight loss alone. Coverage for Wegovy specifically varies widely. If your plan doesn't cover it, HSA and FSA accounts can be used for GLP-1 medication — paying with pre-tax dollars saves 25-35% effectively.
Is It Worth It?
In manufacturer trials of branded semaglutide, average weight loss was substantial; individual results vary and compounded semaglutide has not been studied in those trials. For a 230-pound man, that's 35-40 pounds. Beyond the scale, GLP-1 therapy improves blood pressure, cholesterol, blood sugar, and — for men — can raise testosterone levels by 50-100+ ng/dL through visceral fat reduction alone. When you factor in the downstream health costs of obesity (medications, comorbidities, reduced productivity), the investment often pays for itself.